Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Sean Moran

Sean Moran is recorded as CFO at Corbus Pharmaceuticals Holdings, Inc. (CRBP). The proxy statement of Corbus Pharmaceuticals Holdings, Inc. reports total compensation of $1,789,423 for Sean Moran in fiscal 2025, including a base salary of $481,137. Disclosed compensation is on record for 5 fiscal years. Sean Moran has spoken on 1 earnings call across 1 company, most recently for Corbus Pharmaceuticals Holdings, Inc. on March 15, 2021.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Corbus Pharmaceuticals Holdings, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Corbus Pharmaceuticals Holdings, Inc. (CRBP) $481,137 $1,789,423
2024 Corbus Pharmaceuticals Holdings, Inc. (CRBP) $462,769 $2,429,505
2023 Corbus Pharmaceuticals Holdings, Inc. (CRBP) $444,971 $717,256
2022 Corbus Pharmaceuticals Holdings, Inc. (CRBP) $427,933 $778,616
2021 Corbus Pharmaceuticals Holdings, Inc. (CRBP) $414,054 $1,844,917

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.